As a different approach to obtain optimal triggering of the adaptive anti-tumor immune response, a vaccination strategy with tumor cells transduced with the AIR-1-encoded MHC-II transactivator CIITA [24,25] has been explored in our laboratory. This evidence concerns the gene ZCCHC7 and neoplasm.